| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

There is an urgent need for the discovery of new drugs against infectious diseases and cancer. Globally, infectious diseases are prevalent, with pathogens constantly evolving, leading to a rise in ...

The same genes could hold the key to regenerating cells in the ear and eye, according to a new mouse study. Researchers focused on a group of interacting genes called the Hippo pathway, which serve as ...

"We have discovered new gateways for drugs to modulate proteins that regulate cellular activity," explains Dr. Jana Selent, coordinator of the GPCR Drug Discovery Research ... within the cell will ...

Two patients in the study died, though neither mortality was deemed related to the study drug. Three patients discontinued treatment ... of cancer therapies that target both the PD-1 and VEGF pathways ...

These pathways are subsequently analyzed to uncover novel targets ... which will go toward advancing its drug development pipeline and AI platform developments. By generating high-throughput, ...

About Compass Pathways ... development of our investigational COMP360 psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the US Food ...

The drug came under close watch after a medical professor linked to its development was charged with fraud last year. Neuroscientist Hoau-Yan Wang allegedly submitted false data to get millions of ...

It may be disturbing to characterize human bodies in such commodifying terms, but the unavoidable reality is that human ...